WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Stock Ownership - Who owns Altimmune?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Altimmune Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Raymond M. JordtChief Business Officer2025-07-311,368$3.14
$4.30kBuy
Matthew Scott HarrisChief Medical Officer2025-07-312,018$3.14
$6.34kBuy
M. Scot RobertsChief Scientific Officer2025-07-31846$3.14
$2.66kBuy
Catherine A. SohnDirector2025-03-171,000$5.79
$5.79kBuy
Gregory L. WeaverChief Financial Officer2025-03-1310,000$5.20
$52.00kBuy
Vipin K. GargPresident and CEO2025-02-028,282$6.64
$54.99kSell
Matthew Scott HarrisChief Medical Officer2025-02-022,708$6.64
$17.98kSell
M. Scot RobertsChief Scientific Officer2025-02-022,316$6.64
$15.38kSell
M. Scot RobertsChief Scientific Officer2025-02-011,801$6.64
$11.96kSell
Matthew Scott HarrisChief Medical Officer2025-02-012,109$6.64
$14.00kSell

1 of 3

ALT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALT insiders and whales buy or sell their stock.

ALT Shareholders

What type of owners hold Altimmune Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Prescott Group Capital Management LLC22.48%19,837,273$78.56MInsider
Novartis Bioventures Ltd9.46%8,345,145$33.05MInsider
Blackrock Inc7.22%6,372,560$25.24MInstitution
Luke Evnin7.19%6,347,614$25.14MInsider
Mpm Bioventures III LLC7.19%6,347,614$25.14MInsider
Vanguard Group Inc5.85%5,167,124$20.46MInstitution
Healthcare Ventures VII LP4.96%4,378,057$17.34MInsider
Venrock Healthcare Capital Partners III LP3.97%3,500,000$13.86MInsider
James H. Cavanaugh3.76%3,317,243$13.14MInsider
State Street Corp3.12%2,753,638$10.90MInstitution

1 of 3

ALT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALT37.29%62.71%Net Selling
ACIU24.40%0.00%
CTMX85.98%14.02%Net Selling
DRTS1.87%0.00%
ANNX79.73%20.27%Net BuyingNet Buying
View Top Biotech Stocks

Altimmune Stock Ownership FAQ

Who owns Altimmune?

Altimmune (NASDAQ: ALT) is owned by 42.61% institutional shareholders, 71.65% Altimmune insiders, and 0.00% retail investors. Prescott Group Capital Management LLC is the largest individual Altimmune shareholder, owning 19.84M shares representing 22.48% of the company. Prescott Group Capital Management LLC's Altimmune shares are currently valued at $74.59M.

If you're new to stock investing, here's how to buy Altimmune stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.